Cargando…
Comprehensive characterization of TGFB1 across hematological malignancies
TGFB1, which encodes TGF-β1, a potent cytokine regulating varies cellular processes including immune responses. TGF-β1 plays context-dependent roles in cancers and is increasingly recognized as a therapeutic target to enhance immunotherapy responses. We comprehensively evaluated expression of TGFB1...
Autores principales: | Wang, Cui-zhu, Zhang, Zi-qi, Zhang, Yan, Zheng, Liang-feng, Liu, Yang, Yan, Ai-ting, Zhang, Yuan-cui, Chang, Qing-hua, Sha, Suo, Xu, Zi-jun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10625629/ https://www.ncbi.nlm.nih.gov/pubmed/37925591 http://dx.doi.org/10.1038/s41598-023-46552-8 |
Ejemplares similares
-
No Association between TGFB1 Polymorphisms and Late Radiotherapy Toxicity: A Meta-Analysis
por: Zhu, Mei-Ling, et al.
Publicado: (2013) -
Clinical characteristics and identification of a novel TGFB1 variant in three unrelated Chinese families with Camurati‐Engelmann disease
por: Tao, Xiao‐Hui, et al.
Publicado: (2022) -
TCF12 Activates TGFB2 Expression to Promote the Malignant Progression of Melanoma
por: Tian, Youjia, et al.
Publicado: (2023) -
Chimeric Antigen Receptor T-cell (CAR T) Therapy for Hematologic and Solid Malignancies: Efficacy and Safety—A Systematic Review with Meta-Analysis
por: Yu, Wen-Liang, et al.
Publicado: (2019) -
The Role of CREBBP/EP300 and Its Therapeutic Implications in Hematological Malignancies
por: Zhu, Yu, et al.
Publicado: (2023)